home All News open_in_new Full Article

Las acciones de Novo Nordisk se desploman tras el fracaso de un fármaco contra el Alzheimer

El resultado de un ensayo clínico es un duro golpe para una de las mayores cotizadas de Europa. Novo Nordisk dijo que los ensayos, en los que participaron casi 4.000 pacientes, "no se tradujeron en un retraso en la progresión de la enfermedad". Leer


today 3 w. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 2427316974
Add Watch Country

arrow_drop_down